NCT04355663

Brief Summary

This study investigates whether neuroproprioceptive "facilitation, inhibition" physical therapy induces plastic and adaptive processes of the CNS (white matter integrity changes), if they relate to clinical improvement, and whether therapeutic effect differs between different kinds of therapies.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
92

participants targeted

Target at P75+ for not_applicable multiple-sclerosis

Timeline
Completed

Started May 2015

Longer than P75 for not_applicable multiple-sclerosis

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 20, 2015

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 20, 2017

Completed
2.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2019

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

April 18, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 21, 2020

Completed
3 months until next milestone

Results Posted

Study results publicly available

July 17, 2020

Completed
Last Updated

July 17, 2020

Status Verified

July 1, 2020

Enrollment Period

2 years

First QC Date

April 18, 2020

Results QC Date

May 28, 2020

Last Update Submit

July 2, 2020

Conditions

Keywords

multiple sclerosisphysical therapywhite matter integrityneuroproprioceptive "facilitation, inhibition"functional recoverynetwork reorganizationneurohormonesdehydroepiandrosterone

Outcome Measures

Primary Outcomes (1)

  • White Matter Integrity

    Magnetic resonance imaging on a 3T magnetic resonance scanner (Siemens Trio Tim, Erlangen, Germany) using a 12-channel phased-array head coil. A diffusion tensor was fitted to each voxel of the brain, and a fractional anisotropy (FA) map was created for each subject. The images were further analyzed using tract-based spatial statistics (TBSS). Fractional anisotropy (FA) is a scalar value between zero and one that describes the degree of anisotropy of a diffusion process. A value of zero means that diffusion is isotropic, i.e. it is unrestricted (or equally restricted) in all directions. A value of one means that diffusion occurs only along one axis and is fully restricted along all other directions. FA is a measure often used in diffusion imaging where it is thought to reflect fiber density, axonal diameter, and myelination in white matter. The FA is an extension of the concept of eccentricity of conic sections in 3 dimensions, normalized to the unit range.

    2 months

Secondary Outcomes (4)

  • Berg Balance Scale, BBS

    2 months

  • Timed up and go Test, TUG

    2 months

  • the 12-item Multiple Sclerosis Walking Scale, MSWS - 12

    2 months

  • the 29-item Multiple Sclerosis Impact Scale, MSIS -29

    2 months

Study Arms (3)

Motor program activating therapy

EXPERIMENTAL

MPAT is method developed and verified by our team. In this therapy, patients are corrected into a postural position where the joints are functionally centered. Somatosensory (manual and verbal) stimuli are then applied to activate motor programs in the brain, which then lead to the co-contraction of the patient's whole body when laying, sitting, standing up or moving forward. Activated programs are repeated under various conditions and in different situations and environments to teach the patients to automatically use the acquired motor skills in daily life. Therapy was realized within the ambulatory area of the Department of Neurology at Kralovske Vinohrady University Hospital in Prague.

Behavioral: Motor program activating therapy

Vojta's reflex locomotion

EXPERIMENTAL

VRL is a standard approach for patients with MS in the Czech Republic. In the therapy, global patterns of the reflex locomotion are activated by stimulation of specific zones, with the individual placed in a precisely determined initial position (supine, prone and side laying, low kneeling position). These movement patterns have the qualities of the forward movement (locomotion) and the movement responses are precisely defined. Reflex locomotion (reflex turning and reflex creeping) is used in therapy to activate involuntarily responses of muscle function, which are necessary for spontaneous movements. Therapy was realized at the Department of Rehabilitation and Sport Medicine at Motol University Hospital.

Behavioral: Vojta's reflex locomotion

Functional electric stimulation

EXPERIMENTAL

Functional electric stimulation in the postural corrected position was developed at our workplace. Participants first underwent individual two-hour session consisting of postural correction using MPAT and the device (The WalkAide® System, Innovative Neurotronics Inc., 4999 Aircenter Circle, Suite 103 Reno, NV 89502, USA) programming (28). Patients received the device to use as much as they felt they were able to during their normal daily living activities thereafter.

Behavioral: Functional electric stimulation

Interventions

Pacients underwent two months' therapy consisted of 16 face-to-face sessions (1 hour, twice a week for two months).

Motor program activating therapy

Pacients underwent two months' therapy consisted of 16 face-to-face sessions (1 hour, twice a week for two months).

Vojta's reflex locomotion

Pacients uderwent two months' therapy. They used the whole time Functional electric stimulation during activities of daily living and underwent 2 individual sessions of Motor program activating therapy.

Functional electric stimulation

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • prevailed spastic paraparesis, stable clinical status and treatment in the preceding 3 months determined by neurologist,
  • Expanded Disability Status Scale score (EDSS) max. 7.5

You may not qualify if:

  • other neurological disease or conditions disabling movement

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Rasova K, Buckova B, Prokopiusova T, Prochazkova M, Angel G, Markova M, Hruskova N, Stetkarova I, Spanhelova S, Mares J, Tintera J, Zach P, Musil V, Hlinka J. A Three-Arm Parallel-group Exploratory Trial documents balance improvement without much evidence of white matter integrity changes in people with multiple sclerosis following two months ambulatory neuroproprioceptive "facilitation and inhibition" physical therapy. Eur J Phys Rehabil Med. 2021 Dec;57(6):889-899. doi: 10.23736/S1973-9087.21.06701-0. Epub 2021 Feb 10.

MeSH Terms

Conditions

Multiple SclerosisInhibition, Psychological

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System DiseasesBehavior

Limitations and Caveats

Different availability to undergo therapy and limited supply of the FES device leading to non-uniform distribution of participants within groups; Technical problems with measurement of DTI leading to unreliable or uninterpretable data.

Results Point of Contact

Title
PhDr. Kamila Řasová, Ph.D.
Organization
Third Faculty of Medicine, Charles University

Study Officials

  • Kamila Řasová, Ph.D.

    Third Faculty of Mecicine, Charles Univerzity

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assoc. prof. Kamila Řasová, Ph.D.

Study Record Dates

First Submitted

April 18, 2020

First Posted

April 21, 2020

Study Start

May 20, 2015

Primary Completion

May 20, 2017

Study Completion

August 1, 2019

Last Updated

July 17, 2020

Results First Posted

July 17, 2020

Record last verified: 2020-07

Data Sharing

IPD Sharing
Will not share